Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the major (complete/partial) cytogenetic response (MCyR) rate
Inclusion criteria
- Adult patients with chronic phase Ph+ CML whose disease is resistant following treatment with at least two BCR-ABL tyrosine kinase inhibitors (i.e. imitinib, nilotinib, or dasatinib)